Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Agranulocytosis | x | x | ||
| Aplastic anaemia | x | x | ||
| Haemolytic anaemia | x | x | ||
| Muscle contracture | x | x | ||
| Dermatitis exfoliative | x | x | ||
| Erythema multiforme | x | x | ||
| Rash | x | x | ||
| Blood disorder | x | x | ||
| Hepatitis | x | x | ||
| Hypersensitivity | x | x | ||
| Leukopenia | x | x | ||
| Nephritis interstitial | x | x | ||
| Nephrosis | x | x | ||
| Separation | x | x | ||
| Stevens-Johnson syndrome | x | x | ||
| Thrombocytopenia | x | x | ||
| Burning sensation | x | x | ||
| Hepatic necrosis | x | x | ||
| Skin necrosis | x | x | ||
| Skin discolouration | x | x | ||
| Sepsis | x | x | ||
| Reaction gastrointestinal | x | x | ||
| Bacterial colonisation | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||
|---|---|---|---|---|
| Burns third degree | x | x | ||
| Wound sepsis | x | x | ||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |